表紙
市場調查報告書

合成生物學:全球市場

Synthetic Biology: Global Markets

出版商 BCC Research 商品編碼 224398
出版日期 內容資訊 英文 351 Pages
訂單完成後即時交付
價格
Back to Top
合成生物學:全球市場 Synthetic Biology: Global Markets
出版日期: 2019年12月13日內容資訊: 英文 351 Pages
簡介

預估全球合成生物學市場將從2019年的53億美元,以28.8%的CAGR (複合年均增長率) 於2024年成長至189億美元。

本報告研究全球合成生物學市場,聚焦主要產品、實現技術、因應技術,提供5年預測、策略聯盟、產業結構、競爭情勢、專利、市場推動因素等系統性情報。

第1章 前言

第2章 摘要重點

第3章 概要

  • 合成生物學技術 - 報告研究範圍
  • 合成生物學概述
  • 合成生物學開發階段
  • 合成生物學市場成長推動因素
  • 合成生物學產品全球市場
  • 產品和技術生命週期情況
  • 合成生物學產業

第4章 技術背景

  • 簡介
    • 合成生物學定義
    • 合成生物學歷史
  • 生物學典範轉移
  • 合成生物學:技術概要
  • 實現技術
    • DNA合成/DNA定序成本趨勢
    • DNA合成技術
    • 微流體技術
    • 次世代型定序技術
    • 基因編輯
  • 基因驅動
  • 生物資訊學技術
  • 生物學組件和整合系統技術
    • 合成DAN
    • BioBrick零件
    • 最小基因組和Chassis Organisms
  • 因應產品
  • 路徑工程
    • 研發應用
    • 合成生物學和微生物組
    • 生物燃料原料的合成生物學
    • 合成生物學的微生物組創製

第5章 合成生物學應用

  • 實現技術應用
  • 生物學組件/整合系統應用
    • 合成基因
    • BioBrick零件
    • 整合系統
  • 因應產品應用
    • 醫藥品
    • 工業生物科技
    • 農業
    • 數據儲存

第6章 合成生物學產業

  • 工業生物科技價值鏈
  • 產業結構力量
  • 產品和技術生物週期
  • 定序儀器產業
  • 長序列片段定序技術
  • DNA定序產業
    • 作為治療藥物的寡糖
    • 基因合成工作流程
    • 基因合成價值鏈
    • 基因合成市場細項
  • 基因編集產業
  • 合成生物學生物設計和晶圓代工產業
  • 軟體產業
  • 農業
  • 消費產品產業
  • 化妝品和護膚用品產業
  • 食品飲料產業
  • 醫療照護產業
  • 工業化學產品產業
  • Cell-Free系統產業
  • 企業收購和策略聯盟

第7章 合成生物學市場

  • 產業成長推動因素
    • DNA讀取、寫入、編集技術
    • 設計師生物的角色越來越重要
    • 加速的商業化
    • 合成生物學晶圓代工廠的成長
  • 合成生物學市場:按末端使用者產業
    • 分析市場
    • 醫療市場
    • 工業化學產品市場
    • 農業市場
    • 消費產品市場
    • 食品飲料市場
  • 合成生物學市場:按產品類型
    • 因應產品市場
    • 生物學組件市場
    • 整合系統市場
  • 因應產品市場
    • 競爭優勢來源
    • 醫療市場
    • 消費產品市場
    • 食品飲料市場
    • 化學產品市場
    • 農業市場
  • 區域市場
    • 合成生物學產品:按地區
    • 實現產品 (enabling products) 市場:按地區
    • 核心產品市場:按地區
    • 因應產品 (enabled products) 市場:按地區

第8章 專利

  • 簡介
  • 基礎專利
  • 合成生物學產業專利分析
  • 定序相關專利課題
  • 基因編集相關專利
  • 基因編集專利:Sangamo案例研究

第9章 企業簡介

  • 20N LABS INC.
  • ABEONA THERAPEUTICS LLC
  • ACTIVE MOTIF
  • AEMETIS INC.
  • AGILENT TECHNOLOGIES INC.
  • AJINOMOTO CO. INC.
  • AGRIMETIS LLC
  • AGRIVIDA INC.
  • ALGENUITY
  • AMBRX INC.
  • AMFORA INC.
  • AMYRIS INC.
  • ANSA BIOTECHNOLOGIES INC.
  • ANTHEIA INC.
  • ARBOR BIOTECHNOLOGIES INC.
  • ARCADIA BIOSCIENCES INC.
  • ARCTURUS THERAPEUTICS INC.
  • ARDRA BIO INC.
  • ARZEDA CORP.
  • ASTRAZENECA PLC
  • ATG BIOSYNTHETICS GMBH
  • ATUM
  • AVECIA
  • AZARGEN BIOTECHNOLOGIES PTY LTD.
  • AZITRA INC.
  • BASF AG
  • BAYER AG
  • BEAM THERAPEUTICS INC.
  • BENCHLING
  • BENSON HILL BIOSYSTEMS INC.
  • BIO BASIC INC.
  • BIOCAPITAL HOLDINGS LLC.
  • BIOCELLECTION INC.
  • BIOGEN INC.
  • BIOMAX INFORMATICS AG
  • BIOMX LTD.
  • BIONEER CORP.
  • BIO S&T INC.
  • BIOSYNTIA APS
  • BLUEBIRD BIO INC.
  • B-MOGEN BIOTECHNOLOGIES INC.
  • BOLT THREADS INC.
  • BRISTOL-MYERS SQUIBB CO.
  • BROOKS LIFE SCIENCES
  • CALYSTA INC.
  • CALYXT INC.
  • CARGILL INC.
  • CARIBOU BIOSCIENCES INC.
  • CASEBIA THERAPEUTICS
  • CASZYME
  • CATALOG TECHNOLOGIES INC.
  • CELGENE CORP.
  • CELLECTIS SA
  • CELL-FREE TECHNOLOGY LTD.
  • CENTRIENT PHARMACEUTICALS
  • CHAIN BIOTECHNOLOGY LTD
  • CIBUS INC.
  • CLARA FOODS CO.
  • C-LECTA GMHB
  • CODAGENIX INC.
  • CODEXIS INC.
  • COLORIFIX LTD.
  • CORBION
  • CRONOS GROUP
  • CRISPR THERAPEUTICS AG
  • CROWN LABORATORIES INC.
  • DANAHER CORP.
  • DEMURIS LTD.
  • DESKTOP GENETICS LTD.
  • DNA SCRIPT
  • DOVETAIL GENOMICS LLC
  • DOWDUPONT INC.
  • EDIGENE CORP.
  • EDIGENE INC.
  • EDITAS MEDICINE INC.
  • EGENESIS INC.
  • ELIGO BIOSCIENCE SAS
  • ENDLESS WEST
  • ENEVOLV INC.
  • EPOCH LIFE SCIENCE INC.
  • ETAGEN PHARMA
  • EUROFINS SCIENTIFIC
  • EVONETIX
  • EVOLVA SA
  • EXPEDEON AG
  • EXXONMOBIL CORP.
  • GC INNOVATION AMERICA
  • G+FLAS LIFE SCIENCES INC.
  • GEA ENZYMES
  • GELTOR INC.
  • GENEMED SYNTHESIS INC.
  • GENERAY BIOTECH CO. LTD.
  • GENOMATICA
  • GENSCRIPT
  • GENUS PLC
  • GEVO INC.
  • GILEAD SCIENCES INC.
  • GINKGO BIOWORKS
  • GLAXOSMITHKLINE PLC
  • GLOBAL BIOENERGIES
  • GLOWEE
  • GLYCOSBIO FOOD SCIENCES
  • GLYCOSYN LLC
  • GOODYEAR TIRE & RUBBER CO.
  • GREEN BIOLOGICS LTD.
  • HELIXWORKS TECHNOLOGIES LTD.
  • HOMOLOGY MEDICINES INC.
  • HORIZON DISCOVERY GROUP PLC
  • HUVEPHARMA
  • ILLUMINA INC.
  • IMPOSSIBLE FOODS INC.
  • INDUSTRIAL MICROBES INC.
  • INGENZA LTD.
  • INOVIO PHARMACEUTICALS INC.
  • INSCRIPTA INC.
  • INTELLIA THERAPEUTICS INC.
  • INTERNATIONAL BUSINESS MACHINES
  • INTREXON CORP.
  • JOYN BIO
  • KANEKA CORP.
  • KWS SAAT SE
  • LABGENIUS LTD.
  • LANZATECH
  • LATTICE AUTOMATION INC.
  • LC SCIENCES
  • LCY CHEMICAL CORP.
  • LGC GROUP
  • LOCUS BIOSCIENCES
  • LOGICBIO THERAPEUTICS
  • LUMEN BIOSCIENCE
  • LYGOS INC.
  • MEISSA VACCINEC INC.
  • MERCK KGAA
  • MICROSYNBIOTIX
  • MICROBYRE INC.
  • MICROSOFT CORP.
  • MIRACULEX
  • MILIS BIO LTD.
  • MODERN MEADOW
  • MODULAR GENETICS INC.
  • MOLECULAR ASSEMBLIES INC.
  • MORPHOSYS AG
  • MOTIF INGREDIENTS
  • NEW ENGLAND BIOLABS
  • NOVARTIS PHARMA AG
  • NOVOME BIOTECHNOLOGIES INC.
  • NOVOZYMES A/S
  • NOVVI LLC
  • NUCELIS LLC
  • NUCLERA NUCLEICS LTD.
  • OMEGA BIO-TEK INC.
  • ORAGENICS INC.
  • OXFORD BIOMEDICA PLC
  • OXFORD GENETICS LTD.
  • PAIRWISE PLANTS INC.
  • PFIZER INC.
  • PHIO PHARMACEUTICALS CORP.
  • PHYLOGICA LTD.
  • PHYLUM BIOSCIENCES INC.
  • PHYTOWELT GREEN TECHNOLOGIES GMBH
  • PIVOT BIO
  • POSEIDA THERAPEUTICS INC.
  • PRECISION BIOSCIENCES INC.
  • PROKARIUM HOLDINGS LTD.
  • PROMEGA CORP.
  • PTC THERAPEUTICS, INC.
  • RECOMBINETICS, INC.
  • ROQUETTE FRERES
  • ROYAL DSM NV
  • SAMPLE6 TECHNOLOGIES
  • SANGAMO THERAPEUTICS INC.
  • SAREPTA THERAPEUTICS INC.
  • SCARAB GENOMICS LLC
  • SENTI BIOSCIENCES
  • SGI-DNA INC.
  • SHINEGENE MOLECULAR BIO-TECHNOLOGIES INC.
  • SIGMA ALDRICH CORP.
  • SHERLOCK BIOSCIENCES
  • SILICOLIFE LDA.
  • SOCATI CORP.
  • SPIBER INC.
  • STRING BIO
  • SUGARLOGIX
  • SYNBIOTA
  • SYNBIO TECHNOLOGIES INC.
  • SYNBIOBETA
  • SYNGENTA AG (CHEMCHINA)
  • SYNPROMICS LTD.
  • SYNTHEGO CORP.
  • SYNTHETIC GENOMICS INC.
  • SYNLOGIC THERAPEUTICS
  • SYNTHACE LTD.
  • SYNTHETIC BIOLOGICS INC.
  • SYNTHORX INC.
  • TAKARA BIO
  • TEEWINOT LIFE SCIENCES CORP.
  • TEPHA INC.
  • TESELAGEN BIOTECHNOLOGY INC.
  • THERMO FISHER SCIENTIFIC INC.
  • TIERRA BIOSCIENCES
  • TINCTORIUM BIO
  • TOOLGEN
  • TRANSCRIPTIC INC.
  • TRANSLATE BIO
  • TROPIC BIOSCIENCES UK LTD.
  • TWIST BIOSCIENCE
  • TRITON ALGAE INNOVATIONS LTD.
  • VEDANTA BIOSCIENCES
  • VERSALIS SPA
  • VERTEX PHARMACEUTICALS INC.
  • VIR BIOTECHNOLOGY INC.
  • XYPHOS INC.
  • YIELD10 BIOSCIENCES INC.
  • ZIOPHARM ONCOLOGY, INC.
  • ZYMERGEN
  • ZYMOCHEM INC.

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: BIO066F

Report Highlights:

The global synthetic biology market should grow from $5.3 billion in 2019 to $18.9 billion by 2024 with a compound annual growth rate (CAGR) of 28.8% for the period of 2019-2024.

Enabled synthetic biology market should grow from $2.7 billion in 2019 to $9.9 billion by 2024 with a compound annual growth rate (CAGR) of 30.0% for the period of 2019-2024.

Enabling synthetic biology market should grow from $1.9 billion in 2019 to $6.7 billion by 2024 with a compound annual growth rate (CAGR) of 28.9% for the period of 2019-2024.

Report Scope:

The study scope includes core synthetic biology products (e.g., oligonucleotides, synthetic genes, BioBrick parts, delivery plasmids, chassis organisms, synthetic cells, cell-based and cell-free production systems), enabling technologies (e.g., DNA sequencing, DNA synthesis, gene editing, bioinformatics, specialty media) and enabled technologies (e.g., healthcare, industrial chemicals, consumer products, food and beverage, agriculture) that are already commercialized or are forecast to be commercialized through 2024.

Key synthetic biology technologies and products are analyzed to determine present and future market status, as well as forecasted growth from 2019 to 2024. In-depth discussion of strategic alliances, industry structures, competitive dynamics, patents and market driving forces is also provided.

BCC Research examines the synthetic biology industry by market segment, including DNA sequencing, DNA synthesis, gene editing, synthetic biology foundries and software; as well as the agriculture; consumer products, cosmetics and skin care, food and beverage, healthcare and industrial chemicals enable product sectors.

The role of key strategic alliances and acquisitions from January 2018 to September 2019 is discussed. Emerging markets, including synthetic genes, synthetic-biology-enabled drugs and vaccines, genome-edited crops and chassis organisms; as well as metabolically engineered factories for producing synthetic fuels and specialty chemicals, are analyzed, and more than 215 companies in these fields are highlighted.

Report Includes:

  • 29 data tables and 100 additional tables
  • An overview of the global markets for synthetic biology
  • Analyses of global market trends, with data from 2018, 2019, and projections of compound annual growth rates (CAGRs) through 2024
  • Description of core synthetic biology products i.e. synthetic genes, DNA parts, chassis organisms, and synthetic cells
  • Information on enabling technologies such as DNA sequencing, oligonucleotides, specialty media, and bioinformatics
  • Knowledge about enabled technologies including biofuels, specialty chemicals, diagnostics, pharmaceuticals, and agriculture
  • Analysis of the synthetic biology industry structure, competitors, and intellectual property landscape
  • Assessment of the products and technologies most commercially viable in the immediate and near-future time frame.
  • Comprehensive profiles of leading companies in the industry, including Active Motif, Bayer AG, BASF AG, Cargill Inc., Dowdupont Inc., Glaxosmithkline Plc, Merck KGAA, Novartis Pharma AG, Pfizer Inc. and Thermo Fisher Scientific Inc.

Table of Contents

Chapter 1: Introduction

  • Study Goals and Objectives
  • Reasons for Doing the Study
  • Contribution of the Study and for Whom
  • Scope and Format
  • Methodology
  • Information Sources
  • Geographical Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2: Summary and Highlights

Chapter 3: Overview

  • Synthetic Biology Technologies Covered in this Report
  • Synthetic Biology Overview
  • Development Stage of Synthetic Biology
  • Forces Driving Synthetic Biology Market Growth
  • Global Markets for Synthetic Biology Products
  • Life Cycle Status of Products and Technologies
  • Synthetic Biology Industry

Chapter 4: Technology Background

  • Introduction
    • Synthetic Biology Defined
    • Synthetic Biology History
  • Paradigm Shift in Biology
  • Synthetic Biology Technology Overview
  • Enabling Technologies
    • DNA-Synthesis and DNA-Sequencing Cost Trends
    • DNA-Synthesis Technologies
    • Microfluidic Technologies
    • Next-Generation Sequencing Technologies
    • Gene Editing
  • Gene Drives
  • Bioinformatics Technologies
  • Biologic Components and Integrated Systems Technologies
    • Synthetic DNA
    • BioBrick Parts
    • Minimal Genomes and Chassis Organisms
  • Enabled Products
  • Pathway Engineering
    • Research and Development Applications
    • Synthetic Biology and the Microbiome
    • Synthetic Biology in Biofuels Feedstocks
    • Synthetic Biology Microbiome Initiatives

Chapter 5: Synthetic Biology Applications

  • Enabling Technologies Applications
  • Biologic Components and Integrated Systems Applications
    • Synthetic Genes
    • BioBrick Parts
    • Integrated Systems
  • Enabled Products Applications
    • Pharmaceuticals
    • Industrial Biotechnology Applications
    • Agricultural Applications
    • Data Storage Applications

Chapter 6: Synthetic Biology Industry

  • Industrial Biotechnology Value Chain
  • Industry Structural Forces
  • Products and Technology Life Cycle
  • Sequencing Instruments Industry
  • Long-Read Sequencing Industry
  • DNA Synthesis Industry
    • Oligos as Therapeutics
    • Gene Synthesis Workflow
    • Gene Synthesis Value Chain
    • Synthetic Gene Market Segments
  • Gene Editing Industry
  • Synthetic Biology Organism Design and Foundries Industry
  • Software Industry
  • Agriculture Industry
  • Consumer Products Industry
  • Cosmetics and Skin Care Industry
  • Food and Beverages Industry
  • Healthcare Industry
  • Industrial Chemicals Industry
  • Cell-Free Systems Industry
  • Industry Acquisitions and Strategic Alliances

Chapter 7: Synthetic Biology Markets

  • Industry Growth-Driving Forces
    • DNA Read, Write and Edit Technologies
    • Growing Role of Designer Organisms
    • Speeding up of Commercialization Pathways
    • Growth in Synthetic Biology Foundries
  • Synthetic Biology Markets by End-User Industry
    • Research Market
    • Healthcare Market
    • Industrial Chemicals Market
    • Agriculture Market
    • Consumer Market
    • Food and Beverage Market
  • Synthetic Biology Markets by Product Type
    • Enabling Products Markets
    • Biologic Components Market
    • Integrated Systems Market
  • Enabled Product Markets
    • Sources of Competitive Advantage
    • Healthcare Market
    • Consumer Products Market
    • Food and Beverage Market
    • Chemicals Market
    • Agriculture Market
  • Geographic Markets
    • Synthetic Biology Products by Region
    • Enabling Products Market by Region
    • Core Products Market by Region
    • Enabled Products Market by Region

Chapter 8: Patents

  • Introduction
  • Foundational Patents
  • Synthetic Biology Industry Patent Analysis
  • Sequencing-Related Patent Issues
  • Gene editing-Related Patents
  • Gene Editing Patents: Sangamo Case Study

Chapter 9: Company Profiles

  • 20N LABS INC.
  • ABEONA THERAPEUTICS LLC
  • ACTIVE MOTIF
  • AEMETIS INC.
  • AGILENT TECHNOLOGIES INC.
  • AJINOMOTO CO. INC.
  • AGRIMETIS LLC
  • AGRIVIDA INC.
  • ALGENUITY
  • AMBRX INC.
  • AMFORA INC.
  • AMYRIS INC.
  • ANSA BIOTECHNOLOGIES INC.
  • ANTHEIA INC.
  • ARBOR BIOTECHNOLOGIES INC.
  • ARCADIA BIOSCIENCES INC.
  • ARCTURUS THERAPEUTICS INC.
  • ARDRA BIO INC.
  • ARZEDA CORP.
  • ASTRAZENECA PLC
  • ATG BIOSYNTHETICS GMBH
  • ATUM
  • AVECIA
  • AZARGEN BIOTECHNOLOGIES PTY LTD.
  • AZITRA INC.
  • BASF AG
  • BAYER AG
  • BEAM THERAPEUTICS INC.
  • BENCHLING
  • BENSON HILL BIOSYSTEMS INC.
  • BIO BASIC INC.
  • BIOCAPITAL HOLDINGS LLC.
  • BIOCELLECTION INC.
  • BIOGEN INC.
  • BIOMAX INFORMATICS AG
  • BIOMX LTD.
  • BIONEER CORP.
  • BIO S&T INC.
  • BIOSYNTIA APS
  • BLUEBIRD BIO INC.
  • B-MOGEN BIOTECHNOLOGIES INC.
  • BOLT THREADS INC.
  • BRISTOL-MYERS SQUIBB CO.
  • BROOKS LIFE SCIENCES
  • CALYSTA INC.
  • CALYXT INC.
  • CARGILL INC.
  • CARIBOU BIOSCIENCES INC.
  • CASEBIA THERAPEUTICS
  • CASZYME
  • CATALOG TECHNOLOGIES INC.
  • CELGENE CORP.
  • CELLECTIS SA
  • CELL-FREE TECHNOLOGY LTD.
  • CENTRIENT PHARMACEUTICALS
  • CHAIN BIOTECHNOLOGY LTD
  • CIBUS INC.
  • CLARA FOODS CO.
  • C-LECTA GMHB
  • CODAGENIX INC.
  • CODEXIS INC.
  • COLORIFIX LTD.
  • CORBION
  • CRONOS GROUP
  • CRISPR THERAPEUTICS AG
  • CROWN LABORATORIES INC.
  • DANAHER CORP.
  • DEMURIS LTD.
  • DESKTOP GENETICS LTD.
  • DNA SCRIPT
  • DOVETAIL GENOMICS LLC
  • DOWDUPONT INC.
  • EDIGENE CORP.
  • EDIGENE INC.
  • EDITAS MEDICINE INC.
  • EGENESIS INC.
  • ELIGO BIOSCIENCE SAS
  • ENDLESS WEST
  • ENEVOLV INC.
  • EPOCH LIFE SCIENCE INC.
  • ETAGEN PHARMA
  • EUROFINS SCIENTIFIC
  • EVONETIX
  • EVOLVA SA
  • EXPEDEON AG
  • EXXONMOBIL CORP.
  • GC INNOVATION AMERICA
  • G+FLAS LIFE SCIENCES INC.
  • GEA ENZYMES
  • GELTOR INC.
  • GENEMED SYNTHESIS INC.
  • GENERAY BIOTECH CO. LTD.
  • GENOMATICA
  • GENSCRIPT
  • GENUS PLC
  • GEVO INC.
  • GILEAD SCIENCES INC.
  • GINKGO BIOWORKS
  • GLAXOSMITHKLINE PLC
  • GLOBAL BIOENERGIES
  • GLOWEE
  • GLYCOSBIO FOOD SCIENCES
  • GLYCOSYN LLC
  • GOODYEAR TIRE & RUBBER CO.
  • GREEN BIOLOGICS LTD.
  • HELIXWORKS TECHNOLOGIES LTD.
  • HOMOLOGY MEDICINES INC.
  • HORIZON DISCOVERY GROUP PLC
  • HUVEPHARMA
  • ILLUMINA INC.
  • IMPOSSIBLE FOODS INC.
  • INDUSTRIAL MICROBES INC.
  • INGENZA LTD.
  • INOVIO PHARMACEUTICALS INC.
  • INSCRIPTA INC.
  • INTELLIA THERAPEUTICS INC.
  • INTERNATIONAL BUSINESS MACHINES
  • INTREXON CORP.
  • JOYN BIO
  • KANEKA CORP.
  • KWS SAAT SE
  • LABGENIUS LTD.
  • LANZATECH
  • LATTICE AUTOMATION INC.
  • LC SCIENCES
  • LCY CHEMICAL CORP.
  • LGC GROUP
  • LOCUS BIOSCIENCES
  • LOGICBIO THERAPEUTICS
  • LUMEN BIOSCIENCE
  • LYGOS INC.
  • MEISSA VACCINEC INC.
  • MERCK KGAA
  • MICROSYNBIOTIX
  • MICROBYRE INC.
  • MICROSOFT CORP.
  • MIRACULEX
  • MILIS BIO LTD.
  • MODERN MEADOW
  • MODULAR GENETICS INC.
  • MOLECULAR ASSEMBLIES INC.
  • MORPHOSYS AG
  • MOTIF INGREDIENTS
  • NEW ENGLAND BIOLABS
  • NOVARTIS PHARMA AG
  • NOVOME BIOTECHNOLOGIES INC.
  • NOVOZYMES A/S
  • NOVVI LLC
  • NUCELIS LLC
  • NUCLERA NUCLEICS LTD.
  • OMEGA BIO-TEK INC.
  • ORAGENICS INC.
  • OXFORD BIOMEDICA PLC
  • OXFORD GENETICS LTD.
  • PAIRWISE PLANTS INC.
  • PFIZER INC.
  • PHIO PHARMACEUTICALS CORP.
  • PHYLOGICA LTD.
  • PHYLUM BIOSCIENCES INC.
  • PHYTOWELT GREEN TECHNOLOGIES GMBH
  • PIVOT BIO
  • POSEIDA THERAPEUTICS INC.
  • PRECISION BIOSCIENCES INC.
  • PROKARIUM HOLDINGS LTD.
  • PROMEGA CORP.
  • PTC THERAPEUTICS, INC.
  • RECOMBINETICS, INC.
  • ROQUETTE FRERES
  • ROYAL DSM NV
  • SAMPLE6 TECHNOLOGIES
  • SANGAMO THERAPEUTICS INC.
  • SAREPTA THERAPEUTICS INC.
  • SCARAB GENOMICS LLC
  • SENTI BIOSCIENCES
  • SGI-DNA INC.
  • SHINEGENE MOLECULAR BIO-TECHNOLOGIES INC.
  • SIGMA ALDRICH CORP.
  • SHERLOCK BIOSCIENCES
  • SILICOLIFE LDA.
  • SOCATI CORP.
  • SPIBER INC.
  • STRING BIO
  • SUGARLOGIX
  • SYNBIOTA
  • SYNBIO TECHNOLOGIES INC.
  • SYNBIOBETA
  • SYNGENTA AG (CHEMCHINA)
  • SYNPROMICS LTD.
  • SYNTHEGO CORP.
  • SYNTHETIC GENOMICS INC.
  • SYNLOGIC THERAPEUTICS
  • SYNTHACE LTD.
  • SYNTHETIC BIOLOGICS INC.
  • SYNTHORX INC.
  • TAKARA BIO
  • TEEWINOT LIFE SCIENCES CORP.
  • TEPHA INC.
  • TESELAGEN BIOTECHNOLOGY INC.
  • THERMO FISHER SCIENTIFIC INC.
  • TIERRA BIOSCIENCES
  • TINCTORIUM BIO
  • TOOLGEN
  • TRANSCRIPTIC INC.
  • TRANSLATE BIO
  • TROPIC BIOSCIENCES UK LTD.
  • TWIST BIOSCIENCE
  • TRITON ALGAE INNOVATIONS LTD.
  • VEDANTA BIOSCIENCES
  • VERSALIS SPA
  • VERTEX PHARMACEUTICALS INC.
  • VIR BIOTECHNOLOGY INC.
  • XYPHOS INC.
  • YIELD10 BIOSCIENCES INC.
  • ZIOPHARM ONCOLOGY, INC.
  • ZYMERGEN
  • ZYMOCHEM INC.

List of Tables

  • Summary Table: Global Synthetic Biology Market, by Product Type, Through 2024
    • Table 1: Report Scope
    • Table 2: Synthetic Biology Paradigm
    • Table 3: Synthetic Biology Market Driving Forces, 2019 to 2024
    • Table 4: Global Synthetic Biology Market, by End-User Industry, Through 2024
    • Table 5: Synthetic Biology Products and Technology Life Cycle Stage
    • Table 6: Synthetic Biology Industry, by Market Segment
    • Table 7: Synthetic Biology Definitions
    • Table 8: Synthetic Biology History, 1970-2019
    • Table 9: Paradigm Shift Caused by Synthetic Biology
    • Table 10: Comparison of Genetic Engineering and Synthetic Biology
    • Table 11: Synthetic Biology Applications, by Technology
    • Table 12: Importance of Enabling Technologies
    • Table 13: Cost to Sequence a Single Human Genome, 2001-2019
    • Table 14: DNA-Synthesis Costs, 2006-2019
    • Table 15: Pros and Cons of Gene-Synthesis Technologies
    • Table 16: Importance of Microfluidics Technologies in Synthetic Biology
    • Table 17: Next-Generation Sequencing Technologies, by Company, 2019
    • Table 18: Gene Editing Therapeutic Interventions
    • Table 19: Gene Editing Technology Approaches
    • Table 20: Comparison of the Major Gene Editing Technologies
    • Table 21: Comparison of CRISPR Enzyme Technology
    • Table 22: Potential Market Applications for Gene Drive Modified Organisms
    • Table 23: Synthetic Biology Bioinformatics Technologies
    • Table 24: Comparison of Nucleic Acids, Genes and Genomes
    • Table 25: Synthetic DNA Types
    • Table 26: Synthetic Genes as Molecular-Biology Tools
    • Table 27: Synthetic Genes Versus Traditional Polymerase Chain Reaction Cloning
    • Table 28: Mechanism of DNA Constructs
    • Table 29: Key Attributes of a Minimal Genome
    • Table 30: Enabled Technologies, by Near-Term Application
    • Table 31: Metabolic Engineering for Artemisinic Acid
    • Table 32: Research and Development Applications for Synthetic Biology Products
    • Table 33: Microbiomes: Approaches of Incorporation of Synthetic Biology
    • Table 34: Contribution of Synthetic Biology to Biofuels
    • Table 35: Synthetic Biology Initiatives Relating to the Microbiome
    • Table 36: Synthetic Biology Products Impacted by Enabling Technologies
    • Table 37: Biologic Components and Integrated Systems Near-Term Applications
    • Table 38: Synthetic Genes Near-Term Applications, by End User
    • Table 39: E Coli as a Chassis Organism
    • Table 40: Drug Discovery and Development Applications for Synthetic Biology Products
    • Table 41: Gene Editing Clinical Pipeline, by Company, 2019
    • Table 42: CAR-T Cell Alliances and Synthetic Biology Platforms
    • Table 43: Industrial Biotechnology Applications
    • Table 44: Synthetic Biology Enabled Biofuel Applications
    • Table 45: Growth Status of Specialty Versus Drop-in Biofuels, 2000-2020
    • Table 46: Synthetic Biology Enabled Agriculture and Animal Applications
    • Table 47: U.S. and European Approaches to Regulation of Gene Edited Crops
    • Table 48: Synthetic Biology Industry Structural Forces
    • Table 49: Synthetic Biology Products and Technology Life Cycle Stage
    • Table 50: Advanced Sequencing Industry Company Positioning, 2019
    • Table 51: End-to-End Sequencing Approaches
    • Table 52: Long-Read Sequencing Industry, by Company, 2019
    • Table 53: Nucleic Acid Synthesis Key Competitor Strategies, by Company, 2019
    • Table 54: RNA Therapy Segments
    • Table 55: RNA Therapies Industry
    • Table 56: Gene Synthesis Workflow
    • Table 57: Gene Synthesis Market Factors of Differentiation
    • Table 58: Gene Editing Industry, 2019
    • Table 59: Regulatory Situation of Gene-Edited Crops, by Country or Region
    • Table 60: Clinical-Stage Gene Editing Industry, 2019
    • Table 61: Competitive Platforms: B-Thalassemia
    • Table 62: Competitive Platforms: LCA, 2019
    • Table 63: Organism Design and Automation Industry, 2019
    • Table 64: Market Focus for Selected Synthetic Biology Software Companies, 2019
    • Table 65: Market Segment of Synthetic Biology Agriculture Industry, by Company, 2019
    • Table 66: Market Segment of Consumer Products Industry, by Company, 2019
    • Table 67: Cosmetics and Skin Care Industry, 2019
    • Table 68: Food and Beverage Industry, 2019
    • Table 69: Synthetic Biology-Based Healthcare Industry, 2019
    • Table 70: Microbiome Therapeutics Industry, 2019
    • Table 71: Synthetic Biology-Based Industrial Chemicals Industry, 2019
    • Table 72: Leading Companies in the Cell-Free Synthetic Biology Industry, 2019
    • Table 73: Synthetic Biology Industry Acquisitions, January 2018-September 2019
    • Table 74: Strategic Alliances, January 2018-September 2019
    • Table 75: Forces Driving Growth in the Synthetic Biology Markets
    • Table 76: Global Synthetic Biology Market in Research Applications, by Product Type, Through 2024
    • Table 77: Global Synthetic Biology Market in Healthcare Applications, by Product Type, Through 2024
    • Table 78: Global Synthetic Biology Market for Industrial Chemical Applications, by Product Type, Through 2024
    • Table 79: Global Synthetic Biology Market for Agricultural Applications, by Product Type, Through 2024
    • Table 80: Global Synthetic Biology Market in Consumer Applications, by Product Type, Through 2024
    • Table 81: Global Synthetic Biology Market for Food and Beverage Applications, by Product Type, Through 2024
    • Table 82: Global Synthetic Biology Market, by Product Type, Through 2024
    • Table 83: Global Synthetic Biology Enabling Product Market, by Type, Through 2024
    • Table 84: Global Synthetic Biology Enabling Products Market, by End-User Industry, Through 2024
    • Table 85: Global Synthetic Biologic Components Market, by Type, Through 2024
    • Table 86: Global Synthetic Biologic Components Market, by End-User Industry, Through 2024
    • Table 87: lobal Synthetic Biology Integrated Systems Market, by Type, Through 2024
    • Table 88: Synthetic Biology Microbe Engineering Workflow
    • Table 89: Global Synthetic Biology Integrated Systems Market, by End-User Industry, Through 2024
    • Table 90: Biodiesel Fuel Performance Comparison
    • Table 91: Artemisinin Drug Production Comparison
    • Table 92: Sweetener Product Comparison
    • Table 93: Global Synthetic Biology Enabled Products Market, by End-User Industry, Through 2024
    • Table 94: Global Synthetic Biology Healthcare Market, by Sector, Through 2024
    • Table 95: Global Synthetic Biology Gene editing Therapeutic Market, by Disease Category, Through 2024
    • Table 96: Gene Editing Clinical Pipeline, by Company, 2019
    • Table 97: Global Synthetic Biology Consumer Products Market, by Type, Through 2024
    • Table 98: Global Synthetic Biology Food and Beverage Market, by Type, Through 2024
    • Table 99: Factors for Synthetic Biology-Based Chemical Processes
    • Table 100: Global Synthetic Biology Industrial Chemicals Market, by Product Type, Through 2024
    • Table 101: Advanced Biofuel Growth Factors
    • Table 102: Crude Oil Prices, 2011-2019
    • Table 103: Strategic Shifts in Biofuels, by Company, 2017 and 2018
    • Table 104: Global Synthetic Biology Agriculture Market, by End-User Industry, Through 2024
    • Table 105: Global Synthetic Biology Agriculture Animals Market, by Application, Through 2024
    • Table 106: Mosquito-Control Methods
    • Table 107: Aedes Aegypti Initial Markets, 2019
    • Table 108: Global Synthetic Biology Crop Enhancement Market, by Crop Type, Through 2024
    • Table 109: Advantages of Gene Editing for Crop Enhancement
    • Table 110: Gene-Edited Crop Market Landscape
    • Table 111: Gene Edited Crops Commercialization Pathway
    • Table 112: Global Synthetic Biology Market, by Region, Through 2024
    • Table 113: Global Synthetic Biology Enabling Product Market, by Region, Through 2024
    • Table 114: Global Synthetic Biology Core Products Market, by Region, Through 2024
    • Table 115: Global Synthetic Biology Enabled Products Market, by Region, Through 2024
    • Table 116: Synthetic Biology Patent Scope
    • Table 117: Synthetic Biology Foundational Patents
    • Table 118: Synthetic Biology Representative Patent Grouping, by Tier
    • Table 119: Patent Description, by Company
    • Table 120: Status of Liquid Biopsy and Sequencing-Related Patent Disputes, 2019
    • Table 121: CRISPR-Cas9 Patent Groups
    • Table 122: CRISPR-Cas9 Patent Licensing Fields, by Company
    • Table 123: Sangamo Collaboration Agreements Relating to ZFN Technology
    • Table 124: Sangamo Therapeutics Patent Position
    • Table 125: Agrivida Technical Approach
    • Table 126: Ginkgo Bioworks Engineered-Organism Workflow
    • Table 127: Gene Editing Versus Gene Therapy Approach

List of Figures

  • Summary Figure: Global Synthetic Biology Market, by Product Type, 2017-2024
    • Figure 1: Synthetic Biology Value Added Chain
    • Figure 2: Evolution of Synthetic Biology from Natural to Artificial Systems
    • Figure 3: Conventional versus Synthetic Biology Approach to Gene Synthesis
    • Figure 4: Scale of Synthetic Biology
    • Figure 5: Schematic of Conventional DNA-Synthesis Technologies
    • Figure 6: Microarrays in DNA Synthesis
    • Figure 7: Roles of Promoters and Reporters in Synthetic Biology Systems
    • Figure 8: Creation of Enabled Products Through Synthetic Biology
    • Figure 9: Industrial Biotechnology Value Chain with Synthetic Biology Leverage Points
Back to Top